Impairment of salivary mucin production resulting in declined salivary viscosity during naproxen administration as a potential link to upper alimentary tract mucosal injury.

Clin Transl Gastroenterol · 2013 · PMC3724045 · PMID 23884372

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

1 The salivary mucin output during administration of naproxen/rabeprazole combination increased by 30% in pentagastrin-stimulated conditions from the naproxen/placebo combination, although did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.